BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 30125495)

  • 1. Ultraspecific and Amplification-Free Quantification of Mutant DNA by Single-Molecule Kinetic Fingerprinting.
    Hayward SL; Lund PE; Kang Q; Johnson-Buck A; Tewari M; Walter NG
    J Am Chem Soc; 2018 Sep; 140(37):11755-11762. PubMed ID: 30125495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A guide to nucleic acid detection by single-molecule kinetic fingerprinting.
    Johnson-Buck A; Li J; Tewari M; Walter NG
    Methods; 2019 Jan; 153():3-12. PubMed ID: 30099084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct Kinetic Fingerprinting for High-Accuracy Single-Molecule Counting of Diverse Disease Biomarkers.
    Mandal S; Li Z; Chatterjee T; Khanna K; Montoya K; Dai L; Petersen C; Li L; Tewari M; Johnson-Buck A; Walter NG
    Acc Chem Res; 2021 Jan; 54(2):388-402. PubMed ID: 33382587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultraspecific analyte detection by direct kinetic fingerprinting of single molecules.
    Chatterjee T; Li Z; Khanna K; Montoya K; Tewari M; Walter NG; Johnson-Buck A
    Trends Analyt Chem; 2020 Feb; 123():. PubMed ID: 32863484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Picoliter-Droplet Digital Polymerase Chain Reaction-Based Analysis of Cell-Free Plasma DNA to Assess EGFR Mutations in Lung Adenocarcinoma That Confer Resistance to Tyrosine-Kinase Inhibitors.
    Seki Y; Fujiwara Y; Kohno T; Takai E; Sunami K; Goto Y; Horinouchi H; Kanda S; Nokihara H; Watanabe S; Ichikawa H; Yamamoto N; Kuwano K; Ohe Y
    Oncologist; 2016 Feb; 21(2):156-64. PubMed ID: 26768482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetic fingerprinting to identify and count single nucleic acids.
    Johnson-Buck A; Su X; Giraldez MD; Zhao M; Tewari M; Walter NG
    Nat Biotechnol; 2015 Jul; 33(7):730-2. PubMed ID: 26098451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presence of the minor EGFR T790M mutation is associated with drug-sensitive EGFR mutations in lung adenocarcinoma patients.
    Hashida S; Soh J; Toyooka S; Tanaka T; Furukawa M; Shien K; Yamamoto H; Asano H; Tsukuda K; Hagiwara K; Miyoshi S
    Oncol Rep; 2014 Jul; 32(1):145-52. PubMed ID: 24842519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Digital PCR analysis of plasma cell-free DNA for non-invasive detection of drug resistance mechanisms in EGFR mutant NSCLC: Correlation with paired tumor samples.
    Ishii H; Azuma K; Sakai K; Kawahara A; Yamada K; Tokito T; Okamoto I; Nishio K; Hoshino T
    Oncotarget; 2015 Oct; 6(31):30850-8. PubMed ID: 26334838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BEAMing up for detection and quantification of rare sequence variants.
    Li M; Diehl F; Dressman D; Vogelstein B; Kinzler KW
    Nat Methods; 2006 Feb; 3(2):95-7. PubMed ID: 16432518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid kinetic fingerprinting of single nucleic acid molecules by a FRET-based dynamic nanosensor.
    Khanna K; Mandal S; Blanchard AT; Tewari M; Johnson-Buck A; Walter NG
    Biosens Bioelectron; 2021 Oct; 190():113433. PubMed ID: 34171818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Branch migration based selective PCR for DNA mutation enrichment and detection.
    Chen N; Ouyang X; Lin M; Liu N; Wu T; Xiao X
    Chem Commun (Camb); 2019 Jul; 55(58):8466-8469. PubMed ID: 31265022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The "COLD-PCR approach" for early and cost-effective detection of tyrosine kinase inhibitor resistance mutations in EGFR-positive non-small cell lung cancer.
    Mairinger FD; Vollbrecht C; Streubel A; Roth A; Landt O; Walter HF; Kollmeier J; Mairinger T
    Appl Immunohistochem Mol Morphol; 2014; 22(2):114-8. PubMed ID: 24517913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrasensitive and quantitative detection of EGFR mutations in plasma samples from patients with non-small-cell lung cancer using a dual PNA clamping-mediated LNA-PNA PCR clamp.
    Zhang S; Chen Z; Huang C; Ding C; Li C; Chen J; Zhao J; Miao L
    Analyst; 2019 Feb; 144(5):1718-1724. PubMed ID: 30663747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel assay for allelic discrimination that combines the fluorogenic 5' nuclease polymerase chain reaction (TaqMan) and mismatch amplification mutation assay.
    Glaab WE; Skopek TR
    Mutat Res; 1999 Nov; 430(1):1-12. PubMed ID: 10592313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly sensitive and noninvasive detection of epidermal growth factor receptor T790M mutation in non-small cell lung cancer.
    He C; Zheng L; Xu Y; Liu M; Li Y; Xu J
    Clin Chim Acta; 2013 Oct; 425():119-24. PubMed ID: 23886554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Origin of the T790M mutation and its impact on the clinical outcomes of patients with lung adenocarcinoma receiving EGFR-TKIs.
    Dong Y; Zhou Z; Wang J; Ma L; Liu Z; Wang Y; Song J; Zhang S; Che N
    Pathol Res Pract; 2019 May; 215(5):946-951. PubMed ID: 30760406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorometric detection of EGFR exon 19 deletion mutation in lung cancer cells using graphene oxide.
    Kim DM; Kim DH; Jung W; Lee KY; Kim DE
    Analyst; 2018 Apr; 143(8):1797-1804. PubMed ID: 29561562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultraspecific Multiplexed Detection of Low-Abundance Single-Nucleotide Variants by Combining a Masking Tactic with Fluorescent Nanoparticle Counting.
    Pei X; Lai T; Tao G; Hong H; Liu F; Li N
    Anal Chem; 2018 Mar; 90(6):4226-4233. PubMed ID: 29504392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Approaching real-time molecular diagnostics: single-pair fluorescence resonance energy transfer (spFRET) detection for the analysis of low abundant point mutations in K-ras oncogenes.
    Wabuyele MB; Farquar H; Stryjewski W; Hammer RP; Soper SA; Cheng YW; Barany F
    J Am Chem Soc; 2003 Jun; 125(23):6937-45. PubMed ID: 12783546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Detection of circulating tumor DNA in epidermal growth factor receptor-TKI relapsed non-small cell lung cancer patients using next-generation sequencing and an analysis of the resistant mechanisms].
    Li Y; Zhang FS; Guo L; Ying JM
    Zhonghua Bing Li Xue Za Zhi; 2018 Dec; 47(12):904-909. PubMed ID: 30522169
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.